PARP inhibitors demonstrate synergy with radiation, so investigators tested the efficacy and safety of olaparib plus radium-223 in patients with mCRPC and bone metastases in a phase 2 trial.

RADIUM treatment is an established medical service in Great Britain, as may be gathered from the reports which are issued from year to year, especially by the four important organizations which ...

Radium-223 in mCRPC showed long-term favorable safety, low second primary malignancies/fracture rates, and consistent overall ...

THE discovery of radium was speedily followed by its use in the treatment of cancer, and it was hoped that at last a remedy had been found for this terrible disease. Great interest has been ...

Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones. By using an imaging ...

The administration of Pluvicto within six months of radium-223 treatment proved to be safe and efficacious in patients with metastatic castration-resistant prostate cancer, research showed. Patients ...

Treating patients with metastatic castration-resistant prostate cancer with radium-223 also allowed patients to receive subsequent therapies such as chemotherapy. Treatment with radium-223 was safe ...

Radium 223 is a type of internal radiotherapy treatment. Internal radiotherapy means giving radiotherapy to the cancer from inside the body. You might have it for cancer that began in the prostate and ...